Screener
Syndax Pharmaceuticals SNDX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's enterprise value?
- Syndax Pharmaceuticals (SNDX) reported enterprise value of $2.28B in Q1 2026.
- How has Syndax Pharmaceuticals's enterprise value changed year-over-year?
- Syndax Pharmaceuticals's enterprise value increased by 84.0% year-over-year, from $1.24B to $2.28B.
- What is the long-term trend for Syndax Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's enterprise value has grown at a 13.5% compound annual growth rate (CAGR), from $1.09B to $2.04B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Syndax Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude